4d molecular therapeutics announces first patient dosed in phase 1 clinical trial of 4d-110 by intravitreal injection for the treatment of choroideremia

4d molecular therapeutics (4dmt), a clinical-stage leader in the development of precision-guided aav gene medicines based on directed evolution, annou

ABEO Ratings Summary

ABEO Quant Ranking